Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.
Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Bennett CL, Wootton T, Rumble RB, Dusetzina SB, Virgo KS. Basch E, et al. Among authors: frame jn. J Clin Oncol. 2014 Oct 20;32(30):3436-48. doi: 10.1200/JCO.2013.54.8404. Epub 2014 Sep 8. J Clin Oncol. 2014. PMID: 25199761 Free PMC article. Review.
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF, Hankins L, Steinberg SM, Edison M, Frame JN, Pass H, Nesbitt J, Holden D, Mulshine JL, Glatstein E, Ihde DC. Johnson BE, et al. Among authors: frame jn. J Clin Oncol. 1996 Mar;14(3):806-13. doi: 10.1200/JCO.1996.14.3.806. J Clin Oncol. 1996. PMID: 8622028 Clinical Trial.
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.
O'Shaughnessy JA, Denicoff AM, Venzon DJ, Danforth D, Pierce LJ, Frame JN, Bastian A, Ghosh B, Goldspiel B, Miller L, et al. O'Shaughnessy JA, et al. Among authors: frame jn. Ann Oncol. 1994 Oct;5(8):709-16. doi: 10.1093/oxfordjournals.annonc.a058975. Ann Oncol. 1994. PMID: 7826903 Free article. Clinical Trial.
Building a statewide clinical trials network for cancer care in West Virginia.
Abraham J, Keresztury J, Azar J, Monga M, Bowers T, Jones MP, Tirona MT, Pollock J, Coonley C, Jubelirer S, Frame J, Fogg P, Getto M, Filburn S, Naim J, Lucas D, Petros W, Hall S, Remick SC. Abraham J, et al. W V Med J. 2009 Oct;105 Spec No(Spec No):6-11. W V Med J. 2009. PMID: 19999259 Free PMC article.
Genetic polymorphism of CYP2D6 and lung cancer risk.
Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JC, Pass HI, Caporaso NE, Moir DT, Tucker MA. Shaw GL, et al. Among authors: frame jn. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):215-9. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521436
Debrisoquine metabolism and lung cancer risk.
Shaw GL, Falk RT, Deslauriers J, Frame JN, Nesbitt JC, Pass HI, Issaq HJ, Hoover RN, Tucker MA. Shaw GL, et al. Among authors: frame jn. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):41-8. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7894323
37 results